Asian Growth Leaders With High Insider Ownership June 2026Simplywall·Jun 22, 2026 at 11:13 PM688275-0.70%300497-0.88%
Innovative drug concept stocks continue to be strong, with Menovo hitting a 3-day consecutive limit up, followed by Fushine, BHC, Kingchem, APELOA, and WuXi AppTecWallstreetcn·Mar 26, 2026 at 01:35 AM510660-0.79%603538-2.29%
CRO concept stocks fluctuated and strengthened, with Fushine and Menovo both hitting the daily limit, Kingchem rising more than 10%, and Biocytogen, BHC, and ChemPartner following suitWallstreetcn·Mar 24, 2026 at 01:42 AM688796-4.18%300497-0.88%
A-share innovative drug concept stocks are active again, Sunshine Guojian Pharmaceutical rose over 10% to a new high, Yatai Pharm had two consecutive limit-ups, WECOME rose over 10%, and Baicheng Pharmaceutical, ALK, and Fushine followed suitZhitong·Nov 3, 2025 at 01:48 AM300878-4.28%300497-0.88%
Fushine: Net profit loss of 55.8404 million yuan in the third quarter, a decrease of 40.96%Zhitong·Oct 27, 2025 at 12:31 PM300497-0.88%
A-share innovative drug concept stocks fluctuated and rose, Wolwo Pharma increased by over 10%, Chemexpress rose by over 9%, Fushine, CSBIO, and Medicilon followed suitZhitong·Oct 20, 2025 at 02:42 AM300357+0.51%300255-2.94%
Fushine's subsidiary establishes Weiran Business Alliance (Shanghai) Food Technology Co., LtdZhitong·Sep 25, 2025 at 08:37 AM300497-0.88%
Innovative drug concept stocks surged and then fell back, with Mengke Pharmaceutical dropping over 10%, BrightGene, Bio-S falling over 7%, and YKYY, Konruns, EASTON BIOPHARMACEUTICALS, Fushine among those with the largest declinesZhitong·Sep 25, 2025 at 05:43 AM688166-2.25%301096+1.22%
Huachuang Securities: The commercialization of microbial protein is accelerating, suggesting to pay attention to ANGEL YEAST and FushineZhitong·Sep 1, 2025 at 02:16 AM600298+1.69%300497-0.88%
Fushine Pharmaceuticals released its performance for the first half of the year, with a net loss attributable to the parent company of 6.9112 million yuan, narrowing by 69.23%Zhitong·Aug 26, 2025 at 11:49 AM300497-0.88%
Innovative drugs and CRO concept stocks strengthen again, Sunshine Guojian Pharmaceutical rises over 10%Zhitong·May 27, 2025 at 02:00 AM002099+3.92%688336-8.07%
Fushine: Plans to develop multiple plant-based meat productsZhitong·May 25, 2025 at 10:50 AM300497-0.88%
Fushine: The microbial protein industry is still in its infancy in ChinaZhitong·May 22, 2025 at 12:53 AM300497-0.88%
Fushine Pharmaceuticals released its first-quarter performance, with a net profit attributable to the parent company of 2.2388 million yuan, an increase of 52.46%Zhitong·Apr 25, 2025 at 01:42 PM300497-0.88%